Pfizer Inc
Net seller this quarter
$170M
17
-$62.8M
95.8%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 ALLO | $46.9M | 27.55% | 6.38% | Not reported | Q4 2024 |
 CELC | $29.6M | 17.35% | 0.60% | Not reported | Q4 2024 |
 ARVN | $27.7M | 16.24% | 5.30% | Not reported | Q4 2024 |
 PYXS | $19.5M | 11.43% | 11.09% | Not reported | Q4 2024 |
 WVE | $10.9M | 6.42% | 0.97% | Not reported | Q4 2024 |
 BHVN | $8M | 4.70% | 0.33% | Not reported | Q4 2024 |
 CRBU | $7.88M | 4.63% | 4.43% | Not reported | Q4 2024 |
 SPRO | $5.34M | 3.13% | 4.06% | Not reported | Q4 2024 |
 ZNTL | $3.85M | 2.26% | 1.33% | Not reported | Q4 2024 |
 ORIC | $3.55M | 2.09% | 0.36% | -92.2% | Q4 2024 |
 CRDF | $3.01M | 1.77% | 3.52% | Not reported | Q4 2024 |
 ZURA | $2.88M | 1.69% | 0.56% | -81.0% | Q4 2024 |
 AGMB | $1.04M | 0.61% | 0.22% | Not reported | Q1 2026 |
 BOLT | $134K | 0.08% | 1.63% | Not reported | Q4 2024 |
 NXTC | $73K | 0.04% | 1.09% | -71.1% | Q4 2024 |
 DNA | $30K | 0.02% | 0.00% | Not reported | Q4 2024 |
 SENS | $12.4K | 0.01% | 0.00% | Not reported | Q4 2024 |
| Q1 2026 | |||||
| ORIC | $57.7M | 24.14% | 4.62% | -11.1% | Q4 2024 |
| ALLO | $49.8M | 20.85% | 9.00% | Not reported | Q4 2024 |
| ARVN | $34.9M | 14.63% | 5.36% | Not reported | Q4 2024 |
| CELC | $31.3M | 13.13% | 0.61% | -15.4% | Q4 2024 |
| ZURA | $16.8M | 7.05% | 2.99% | -4.4% | Q4 2024 |
| WVE | $11.9M | 5.00% | 0.97% | Not reported | Q4 2024 |
| PYXS | $9.21M | 3.86% | 11.19% | Not reported | Q4 2024 |
| CRBU | $8.35M | 3.50% | 4.84% | Not reported | Q4 2024 |
| SPRO | $5.5M | 2.31% | 4.08% | Not reported | Q4 2024 |
| BHVN | $4.23M | 1.77% | 0.34% | Not reported | Q4 2024 |
| CRDF | $3.74M | 1.57% | 3.53% | Not reported | Q4 2024 |
| ZNTL | $2M | 0.84% | 1.34% | Not reported | Q4 2024 |
| NXTC | $1.54M | 0.64% | 4.25% | -2.7% | Q4 2024 |
| AGMB | $814K | 0.34% | 0.22% | New | Q1 2026 |
 QTTB | $737K | 0.31% | 0.69% | -63.4% | Q4 2024 |
| BOLT | $137K | 0.06% | 1.63% | Not reported | Q4 2024 |
| DNA | $17.4K | 0.01% | 0.00% | Not reported | Q4 2024 |
| SENS | $14.2K | 0.01% | 0.01% | Not reported | Q4 2024 |
| Q4 2025 | |||||
| ORIC | $44M | 18.60% | 5.46% | Not reported | Q4 2024 |
| ARVN | $41M | 17.34% | 5.45% | Not reported | Q4 2024 |
| CELC | $34.8M | 14.74% | 0.72% | Not reported | Q4 2024 |
| WVE | $31.9M | 13.48% | 1.00% | Not reported | Q4 2024 |
| ALLO | $30.2M | 12.76% | 9.60% | Not reported | Q4 2024 |
| ZURA | $15.6M | 6.58% | 4.03% | Not reported | Q4 2024 |
| PYXS | $8.09M | 3.42% | 11.22% | Not reported | Q4 2024 |
| CRBU | $7.46M | 3.15% | 4.93% | Not reported | Q4 2024 |
| CRDF | $6.78M | 2.87% | 3.53% | Not reported | Q4 2024 |
| BHVN | $5.71M | 2.41% | 0.38% | Not reported | Q4 2024 |
| SPRO | $5.5M | 2.33% | 4.19% | Not reported | Q4 2024 |
| NXTC | $2.24M | 0.95% | 4.50% | Not reported | Q4 2024 |
| ZNTL | $1.29M | 0.54% | 1.38% | Not reported | Q4 2024 |
| QTTB | $922K | 0.39% | 2.16% | Not reported | Q4 2024 |
 ANTX | $815K | 0.34% | 2.61% | Not reported | Q4 2024 |
| BOLT | $171K | 0.07% | 1.63% | Not reported | Q4 2024 |
| DNA | $24.3K | 0.01% | 0.01% | Not reported | Q4 2024 |
| SENS | $12K | 0.01% | 0.01% | 0.0% | Q4 2024 |
| Q3 2025 | |||||
 BNTX | $164M | 37.39% | 0.69% | -54.7% | Q4 2024 |
| ORIC | $64.5M | 14.75% | 5.53% | Not reported | Q4 2024 |
| TRML | $60.8M | 13.91% | 4.95% | Not reported | Q4 2024 |
| ARVN | $29.5M | 6.73% | 4.88% | Not reported | Q4 2024 |
| ALLO | $27.3M | 6.25% | 9.87% | Not reported | Q4 2024 |
| CELC | $17.3M | 3.95% | 0.81% | Not reported | Q4 2024 |
| PYXS | $15.6M | 3.57% | 11.32% | Not reported | Q4 2024 |
| WVE | $13.7M | 3.14% | 1.17% | Not reported | Q4 2024 |
| ZURA | $12.9M | 2.94% | 4.57% | Not reported | Q4 2024 |
| CRBU | $10.9M | 2.50% | 5.02% | Not reported | Q4 2024 |
| BHVN | $7.59M | 1.73% | 0.48% | Not reported | Q4 2024 |
| CRDF | $4.97M | 1.14% | 3.59% | Not reported | Q4 2024 |
| SPRO | $4.44M | 1.02% | 4.20% | Not reported | Q4 2024 |
| ZNTL | $1.44M | 0.33% | 1.32% | Not reported | Q4 2024 |
| NXTC | $924K | 0.21% | 5.89% | +1100.0% | Q4 2024 |
| ANTX | $908K | 0.21% | 2.61% | Not reported | Q4 2024 |
| QTTB | $550K | 0.13% | 2.26% | Not reported | Q4 2024 |
| BOLT | $167K | 0.04% | 1.63% | Not reported | Q4 2024 |
| DNA | $42.7K | 0.01% | 0.01% | Not reported | Q4 2024 |
| SENS | $18.9K | 0.00% | 0.11% | Not reported | Q4 2024 |